Serial Number | 97326429 |
Word Mark | GESIFY |
Filing Date | Wednesday, March 23, 2022 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, February 12, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 16, 2023 |
Goods and Services | Pharmaceutical formulations and preparations to treat acute and chronic health conditions related to gastrointestinal, inflammatory, metabolic, endocrine, immunological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, psychiatric, dermatological, and viral diseases and disorders; Pharmaceutical compositions in liquid form, namely, liquid compositions containing protease inhibitors, to treat health conditions, diseases, and disorders related to the gastrointestinal tract, gastrointestinal permeability, the gastrointestinal epithelial barrier, gastrointestinal inflammation, the gastrointestinal immune system, the microbiome, and the gut-brain axis; Pharmaceutical formulations and preparations to treat or prevent surgical complications and postsurgical complications; Pharmaceutical formulations and preparations to treat or prevent shock, namely, acute shock, cardiogenic shock, septic shock, hemorrhagic shock, and shock associated with hypoperfusion; Pharmaceutical formulations and preparations to treat or prevent gastrointestinal dysfunction, gastrointestinal tract injuries, ileus, and adhesions; Pharmaceutical formulations and preparations to accelerate the time to return of bowel function in patients undergoing abdominal surgery; Pharmaceutical formulations to reduce the formation of adhesions following abdominal or pelvic surgery; Pharmaceutical formulations and preparations to treat or prevent multiorgan failure; Pharmaceutical formulations and preparations to treat or prevent health conditions, diseases, and disorders related to intestinal permeability, the microbiome, and the gut-brain axis |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, March 29, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | PALISADE BIO, INC. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Carlsbad, CA 92008 |
Party Name | PALISADE BIO, INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Carlsbad, CA 92008 |
Event Date | Event Description |
Saturday, March 26, 2022 | NEW APPLICATION ENTERED |
Tuesday, March 29, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, January 5, 2023 | ASSIGNED TO EXAMINER |
Thursday, January 5, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, January 5, 2023 | NON-FINAL ACTION E-MAILED |
Thursday, January 5, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, April 4, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, April 4, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, April 4, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Tuesday, April 4, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, April 5, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, April 5, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, April 6, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, April 10, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 26, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 16, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, May 16, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 11, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Monday, February 12, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
Monday, February 12, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |